कृपया अन्य खोज का प्रयास करें
CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs. It is developing homogeneous antibody drugs, such as CHO-H01, CHO-H02, and CHO-A04, a humanized monoclonal antibody for cancer; CHO-H03, a homogeneous antibody drug for autoimmune diseases; CHO-S05 dual-effect anti-flu drugs; and CHO-V08 for Klebsiella pneumonia. The company was founded in 2012 and is based in Taipei City, Taiwan.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Chinh-Yi Wu | - | 2022 | GM & Board Member |
Ming-Hsing Tsai | 66 | 2022 | Director |
Chao-Long Chen | - | - | Chairman |
Shaw T. Chen | - | - | Member of Scientific Advisory Board |
Chi-Huey Wong | - | - | Chairman of Scientific Advisory Board |
Hsieng S. Lu | - | - | Member of Scientific Advisory Board |
Shuan-Ta Liu | - | 2019 | Independent Director |
Kuo-I Lin | - | 2021 | Member of Scientific Advisory Board |
Che Alex Ma | - | - | Member of Scientific Advisory Board |
Pan-Chyr Yang | - | - | Member of Scientific Advisory Board |
Chung-Yi Wu | - | 2022 | President, CEO, GM & Director |
Yun-Ching Yeh | - | 2022 | Board Member |
Victor Ma | - | 2022 | Board Member |
Mei-Shang Ho | - | 2021 | Member of Scientific Advisory Board |
Hong-Nerng Ho | - | - | Independent Director |
Chung-Liang Chien | - | - | Independent Director |
Shun-Ling Chen | - | 2022 | Board Member |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है